Who owns CYTOKINETICS INC?
- CUSIP Number: 23282wac4
Tip: Access positions for across all investors
Analyze quarterly positions in Cytokinetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytokinetics stock
Who bought or sold CYTOKINETICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 96M | $170M | 8% | Dec 2023 |
|
| Weiss Asset Management LP[1 | 47M | $82M | 100% | Dec 2023 |
|
| D. E. Shaw & Co | 29M | $52M | 7% | Dec 2023 |
|
| Balyasny Asset Management | 21M | $37M | 100% | Dec 2023 |
|
| Millennium Management | 21M | $36M | 150% | Dec 2023 |
|
| DeepCurrents Investment Group | 20M | $35M | 0% | Dec 2023 |
|
| Graham Capital Management | 17M | $30M | 100% | Dec 2023 |
|
| Point72 Asset Management | 17M | $30M | -26% | Dec 2023 |
|
| Readystate Asset Management | 15M | $27M | -53% | Dec 2023 |
|
| Polygon Management | 11M | $20M | -68% | Dec 2023 |
|
| CNH Partners | 11M | $20M | -38% | Dec 2023 |
|
| Jane Street | 11M | $19M | -7% | Dec 2023 |
|
| Partner Fund Management | 8.0M | $14M | -68% | Dec 2023 |
|
| Polar Securities | 7.5M | $13M | -74% | Dec 2023 |
|
| Lord, Abbett & Co | 7.1M | $13M | 61% | Dec 2023 |
|
| CSS | 6.4M | $11M | 100% | Dec 2023 |
|
| SSI Investment Management | 4.9M | $8.6M | 38% | Dec 2023 |
|
| Capstone Investment Advisors | 4.7M | $8.2M | -82% | Dec 2023 |
|
| Citadel Advisors | 4.0M | $7.1M | 100% | Dec 2023 |
|
| Citigroup | 3.1M | $5.5M | -20% | Dec 2023 |
|
| Nicholas Investments Partners | 3.0M | $5.3M | 20% | Dec 2023 |
|
| Man Group | 2.6M | $4.5M | -9% | Dec 2023 |
|
| Royal Bank of Canada | 2.2M | $3.9M | 11% | Dec 2023 |
|
| Wellington Management Company | 2.2M | $3.8M | 0% | Dec 2023 |
|
| Shenkman Capital Management | 1.7M | $3.0B | 100% | Dec 2023 |
|
| Credit Suisse | 1.6M | $1.5M | 0% | Dec 2023 |
|
| Aequim Alternative Investments | 1.5M | $2.6M | -50% | Dec 2023 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 1.5M | $2.6M | -14% | Dec 2023 |
|
| Barclays | 1.2M | $2.1M | 146% | Dec 2023 |
|
| Edmond De Rothschild Holding | 1.2M | $2.1M | 0% | Dec 2023 |
|
| Goldman Sachs Group | 938k | $1.6M | -14% | Dec 2023 |
|
| Lazard Asset Management | 500k | $880k | -83% | Dec 2023 |
|
| Bank of New York Mellon | 200k | $317k | -50% | Mar 2024 |
|
| Bank of America Corporation | 175k | $307k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 85k | $150k | -98% | Dec 2023 |
|
| First Hawaiian Bank | 78k | $124k | -21% | Mar 2024 |
|
| SG Americas Securities | 22k | $4.1M | 100% | Dec 2023 |
|
| Nomura Holdings | 5.7k | $480k | -91% | Dec 2023 |
|
Who sold out of Cytokinetics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| III Capital Management | Sep 2023 | 7.5M | $6.4M |
| Bank Of Montreal | Sep 2023 | 2.1M | $1.9M |
| Stonegate Investment Group | Dec 2023 | 11k | $19k |
| Context Capital Management | Sep 2023 | 8.5k | $7.2M |